ORIGIN ENDOSCOPY INC.: Development of EpiMAX, a first-in-class injectable hemostatic agent for long-acting hemostasis of gastrointestinal bleeding
ORIGIN ENDOSCOPY INC. (Baltimore, Maryland): Development of EpiMAX, a first-in-class injectable hemostatic agent for long-acting hemostasis of gastrointestinal bleeding. Its award of $1,212,289 is top-decile (90th percentile of 10,712 records). Dated 51 days ago, it serves as a historical benchmark. Score 70/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $1,212,289 · 90th percentile of 10,712 NihBiotechGrantPulse records · 3.0x the median
Free preview: all 10 published fields of this record are shown below. Locked: 462 related MD NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | ORIGIN ENDOSCOPY INC. |
| Location | BALTIMORE, MD |
| Project | Development of EpiMAX, a first-in-class injectable hemostatic agent for long-acting hemostasis of gastrointestinal bleeding |
| Project number | 1R44DK145328-01A1 |
| Mechanism | R44 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $1,212,289 |
| Awarded | 2026-09-14 |
| Project period | 2026-09-15 to 2028-08-31 |
| UEI | FNG7WGQLJ2U6 |
| award percentile | 90th of 10,712 (median $407,048, 3.0x median) |
| Peer records CSV (463 MD records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch ORIGIN ENDOSCOPY INC.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock ORIGIN ENDOSCOPY + all 463 MD records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-09-14
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (MD first): JOHNS HOPKINS UNIVERSITY · WESTAT, INC. · JOHNS HOPKINS UNIVERSITY · JOHNS HOPKINS UNIVERSITY · JOHNS HOPKINS UNIVERSITY · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: ORIGIN ENDOSCOPY INC. and 463 Maryland peers
- Maryland NihBiotechGrantPulse records like this one: 463
- ORIGIN ENDOSCOPY INC.'s award: 90th percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every Maryland peer: $92,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
70 / 100 Lab Budget Score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for ORIGIN ENDOSCOPY INC. in Baltimore, Maryland?
ORIGIN ENDOSCOPY INC. received an NIH award of $1,212,289 on 2026-09-14: Development of EpiMAX, a first-in-class injectable hemostatic agent for long-acting hemostasis of gastrointestinal bleeding.
How does ORIGIN ENDOSCOPY INC. compare to other Maryland NihBiotechGrantPulse records?
This is a top-decile record: its award of $1,212,289 is 3.0x the median of $407,048 across 10,712 records. It is 51 days old; check the official source for later updates before acting. Its Lab Budget Score of 70/100 puts it among the stronger signals in this feed.
ORIGIN ENDOSCOPY INC. vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date | Compare |
|---|---|---|---|---|---|
| ORIGIN ENDOSCOPY INC. | BALTIMORE, MD | 1,212,289 | 90th | 2026-09-14 | This record |
| REMEDY PLAN | GAITHERSBURG, MD | 1,181,436 | 90th | 2026-09-17 | Compare ORIGIN ENDOSCOPY INC. vs REMEDY PLAN → |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | 1,093,226 | 89th | 2026-09-19 | View record → |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | 1,397,340 | 92nd | 2026-09-18 | View record → |
Related records
NihBiotechGrantPulse: records in Maryland NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More Maryland public-record feeds
eMaryland Marketplace Bids Pulse in Maryland New Trucking Company Registrations in Maryland Maryland Registered Products Pulse in Maryland FEMA Hazard Mitigation Project Tracker in Maryland Montgomery County MD HHS - Food Inspection Data from July 2024 and on Pulse in Maryland HIPAA Breach Reports (500+ Individuals) by State & Type in Maryland Newly Posted IRS Automatic Revocations of Tax Exemption in Maryland Federal Alcohol Permit Holder Directory in Maryland
How to monitor ORIGIN ENDOSCOPY INC. and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like ORIGIN ENDOSCOPY INC. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.